In any case, there was no mortality signal associated with alteplase administered up to 24 hours after a stroke in HOPE.

The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours ...

VOV.VN - Tam Anh General Hospital System has launched the Somatom Force VB30, a cutting-edge CT scanner from Germany that ...

Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke: Tacoma, Washington Friday, February 7, 2025, 18:00 Hrs [IST] Rev ...

Use of endovascular thrombectomy in patients with acute ischemic stroke caused by occlusions in distal vessels has failed to ...

During an ischemic stroke, blood vessels in the brain are blocked or narrowed. During a hemorrhagic stroke, there's bleeding ...

A team in Pittsburgh received a $2.3 million grant to fast-track the development and clinical transition of a minimally ...

This prospective case-control study included 85 patients with lung involvement related to the COVID-19 virus and a group of ...

In a randomized clinical trial in China, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms ...

Though Columbus offers over 50 warming shelters, they aren't a perfect solution. Deaths of unhoused out in the cold aren't ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...